CN117694480A - 一种适用于血糖偏高人群膳食营养补充的复合多维固体饮料配方及其制备工艺 - Google Patents
一种适用于血糖偏高人群膳食营养补充的复合多维固体饮料配方及其制备工艺 Download PDFInfo
- Publication number
- CN117694480A CN117694480A CN202410127411.0A CN202410127411A CN117694480A CN 117694480 A CN117694480 A CN 117694480A CN 202410127411 A CN202410127411 A CN 202410127411A CN 117694480 A CN117694480 A CN 117694480A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- powder
- calcium
- preparation process
- people
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008280 blood Substances 0.000 title claims abstract description 38
- 210000004369 blood Anatomy 0.000 title claims abstract description 38
- 238000002360 preparation method Methods 0.000 title claims abstract description 28
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 23
- 230000035764 nutrition Effects 0.000 title claims abstract description 22
- 235000013361 beverage Nutrition 0.000 title claims abstract description 20
- 235000005911 diet Nutrition 0.000 title claims abstract description 20
- 230000000378 dietary effect Effects 0.000 title claims abstract description 20
- 150000001875 compounds Chemical class 0.000 title claims abstract description 19
- 239000007787 solid Substances 0.000 title claims abstract description 19
- 239000013589 supplement Substances 0.000 title claims abstract description 18
- 238000009472 formulation Methods 0.000 title description 2
- 239000000843 powder Substances 0.000 claims abstract description 85
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims abstract description 34
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 34
- 229940088594 vitamin Drugs 0.000 claims abstract description 25
- 229930003231 vitamin Natural products 0.000 claims abstract description 25
- 235000013343 vitamin Nutrition 0.000 claims abstract description 25
- 239000011782 vitamin Substances 0.000 claims abstract description 25
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims abstract description 20
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 20
- 229920002498 Beta-glucan Polymers 0.000 claims abstract description 20
- 235000020230 cinnamon extract Nutrition 0.000 claims abstract description 20
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 17
- 229920001202 Inulin Polymers 0.000 claims abstract description 17
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 17
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims abstract description 17
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims abstract description 17
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims abstract description 17
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 17
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 17
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims abstract description 17
- 239000011575 calcium Substances 0.000 claims abstract description 17
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 17
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims abstract description 17
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 claims abstract description 17
- 239000001354 calcium citrate Substances 0.000 claims abstract description 17
- 239000004222 ferrous gluconate Substances 0.000 claims abstract description 17
- 235000013924 ferrous gluconate Nutrition 0.000 claims abstract description 17
- 229960001645 ferrous gluconate Drugs 0.000 claims abstract description 17
- 229960000304 folic acid Drugs 0.000 claims abstract description 17
- 235000019152 folic acid Nutrition 0.000 claims abstract description 17
- 239000011724 folic acid Substances 0.000 claims abstract description 17
- 229940087603 grape seed extract Drugs 0.000 claims abstract description 17
- 235000002532 grape seed extract Nutrition 0.000 claims abstract description 17
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 17
- 229940029339 inulin Drugs 0.000 claims abstract description 17
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical compound [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 claims abstract description 17
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims abstract description 17
- 239000000395 magnesium oxide Substances 0.000 claims abstract description 17
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims abstract description 17
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 claims abstract description 17
- 235000001968 nicotinic acid Nutrition 0.000 claims abstract description 17
- 229960003512 nicotinic acid Drugs 0.000 claims abstract description 17
- 239000011664 nicotinic acid Substances 0.000 claims abstract description 17
- 229960000342 retinol acetate Drugs 0.000 claims abstract description 17
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 claims abstract description 17
- 235000019173 retinyl acetate Nutrition 0.000 claims abstract description 17
- 239000011770 retinyl acetate Substances 0.000 claims abstract description 17
- 239000011669 selenium Substances 0.000 claims abstract description 17
- 229910052711 selenium Inorganic materials 0.000 claims abstract description 17
- 235000011649 selenium Nutrition 0.000 claims abstract description 17
- 235000013337 tricalcium citrate Nutrition 0.000 claims abstract description 17
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims abstract description 17
- 239000001717 vitis vinifera seed extract Substances 0.000 claims abstract description 17
- 235000021119 whey protein Nutrition 0.000 claims abstract description 17
- 239000011670 zinc gluconate Substances 0.000 claims abstract description 17
- 235000011478 zinc gluconate Nutrition 0.000 claims abstract description 17
- 229960000306 zinc gluconate Drugs 0.000 claims abstract description 17
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 claims abstract description 16
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 claims abstract description 16
- 239000003094 microcapsule Substances 0.000 claims abstract description 16
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims abstract description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 10
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 10
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 10
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 10
- 239000011709 vitamin E Substances 0.000 claims abstract description 10
- 229940046009 vitamin E Drugs 0.000 claims abstract description 10
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 5
- 229960000869 magnesium oxide Drugs 0.000 claims abstract description 5
- 235000012245 magnesium oxide Nutrition 0.000 claims abstract description 5
- 229940091258 selenium supplement Drugs 0.000 claims abstract description 5
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 5
- 239000011718 vitamin C Substances 0.000 claims abstract description 5
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 20
- 239000000047 product Substances 0.000 claims description 13
- 238000012856 packing Methods 0.000 claims description 12
- 235000010469 Glycine max Nutrition 0.000 claims description 11
- 244000068988 Glycine max Species 0.000 claims description 11
- 235000018102 proteins Nutrition 0.000 claims description 11
- 102000004169 proteins and genes Human genes 0.000 claims description 11
- 108090000623 proteins and genes Proteins 0.000 claims description 11
- 238000004806 packaging method and process Methods 0.000 claims description 10
- 239000000284 extract Substances 0.000 claims description 4
- 238000007689 inspection Methods 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 239000011265 semifinished product Substances 0.000 claims description 4
- 235000019156 vitamin B Nutrition 0.000 claims description 4
- 239000011720 vitamin B Substances 0.000 claims description 4
- 108010073771 Soybean Proteins Proteins 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 235000019710 soybean protein Nutrition 0.000 claims description 3
- 230000009469 supplementation Effects 0.000 claims 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 1
- 229930003270 Vitamin B Natural products 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 9
- 201000001421 hyperglycemia Diseases 0.000 abstract description 7
- 235000015097 nutrients Nutrition 0.000 abstract description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract description 5
- 235000010755 mineral Nutrition 0.000 abstract description 5
- 239000011707 mineral Substances 0.000 abstract description 5
- 102000015781 Dietary Proteins Human genes 0.000 abstract description 4
- 108010010256 Dietary Proteins Proteins 0.000 abstract description 4
- 108010064851 Plant Proteins Proteins 0.000 abstract description 4
- 235000021120 animal protein Nutrition 0.000 abstract description 4
- 235000013325 dietary fiber Nutrition 0.000 abstract description 4
- 210000004185 liver Anatomy 0.000 abstract description 4
- 239000000419 plant extract Substances 0.000 abstract description 4
- 235000021118 plant-derived protein Nutrition 0.000 abstract description 4
- 229940071440 soy protein isolate Drugs 0.000 abstract description 3
- 230000004153 glucose metabolism Effects 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 235000015872 dietary supplement Nutrition 0.000 abstract 1
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 12
- 230000001603 reducing effect Effects 0.000 description 8
- 102000004877 Insulin Human genes 0.000 description 6
- 108090001061 Insulin Proteins 0.000 description 6
- 229940125396 insulin Drugs 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 5
- 230000004060 metabolic process Effects 0.000 description 5
- OOCCDEMITAIZTP-QPJJXVBHSA-N (E)-cinnamyl alcohol Chemical compound OC\C=C\C1=CC=CC=C1 OOCCDEMITAIZTP-QPJJXVBHSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 238000007873 sieving Methods 0.000 description 3
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010022489 Insulin Resistance Diseases 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- OOCCDEMITAIZTP-UHFFFAOYSA-N allylic benzylic alcohol Natural products OCC=CC1=CC=CC=C1 OOCCDEMITAIZTP-UHFFFAOYSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229940117916 cinnamic aldehyde Drugs 0.000 description 2
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000036996 cardiovascular health Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 230000003636 fecal output Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000004110 gluconeogenesis Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 235000001705 insufficient nutrition Nutrition 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000007413 intestinal health Effects 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
- A23L33/165—Complexes or chelates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明涉及一种适用于血糖偏高人群膳食营养补充的复合多维固体饮料配方及其制备工艺，由下列成分组成：大豆分离蛋白粉、浓缩乳清蛋白粉、菊粉、红枣粉、燕麦β‑葡聚糖、柠檬酸钙、磷酸氢钙、氧化镁、葡萄糖酸亚铁、葡萄糖酸锌、富硒麦芽粉、醋酸维生素A、维生素B1、维生素B2、维生素B6、维生素B12、维生素C、维生素D3、维生素E、烟酸、叶酸、D‑泛酸钙、葡萄籽提取物、叶黄素酯微囊粉、肉桂提取物。本发明配方包含动物蛋白、植物蛋白、膳食纤维、维生素、矿物质及植物提取物等营养素，辅助人体肝脏血糖代谢，作为高血糖人群日常膳食营养补充，且该产品配比科学合理，无毒副作用，制备工艺简单成熟，针对血糖偏高者人群长期服用，具有显著效果。
Description
技术领域
本发明涉及饮料配方技术领域，具体为一种适用于血糖偏高人群膳食营养补充的复合多维固体饮料配方及其制备工艺。
背景技术
随着现代生活方式的改变，血糖偏高问题日益普遍。长期血糖偏高不仅影响人们的生活质量，还可能引发多种慢性疾病，如糖尿病等。目前市场上针对血糖偏高人群的食品多数注重单一的营养成分或功能，如低糖、高纤维等，缺乏综合性、科学性的配方。此外，传统的固体饮料制备工艺也存在一些局限性，如口感、营养成分的保留和产品稳定性等方面的问题。
因此急需一种针对血糖偏高人群，补充多维的营养物质，提升机体机能、控制血糖的复合多维固体饮料。
发明内容
本发明为了解决现有技术的问题，提供了一种适用于血糖偏高人群膳食营养补充的复合多维固体饮料配方及其制备工艺。
为了解决上述技术问题，本发明是通过以下技术方案实现的：一种适用于血糖偏高人群膳食营养补充的复合多维固体饮料配方及其制备工艺，由下列成分重量占比组成：大豆分离蛋白粉10％-38％、浓缩乳清蛋白粉10％-38％、菊粉10％-21％、红枣粉14％-16％、燕麦β-葡聚糖2％-4.5％、柠檬酸钙1％-4.15％、磷酸氢钙1％-3.1％、氧化镁0.22％-0.34％、葡萄糖酸亚铁0.08％-0.17％、葡萄糖酸锌0.05％-0.12％、富硒麦芽粉0.0025％-0.01％、醋酸维生素A0.001％-0.0017％、维生素B10.001％-0.002％、维生素B20.001％-0.002％、维生素B60.001％-0.002％、维生素B120.000001％-0.000006％、维生素C0.1％-0.2％、维生素D30.000001％-0.000002％、维生素E0.008％-0.018％、烟酸0.011％-0.03％、叶酸0.0001％-0.0006％、D-泛酸钙0.003％-0.008％、葡萄籽提取物0.1％-0.5％、叶黄素酯微囊粉0.005％-0.15％、肉桂提取物0.15％-0.75％。
优选的，一种适用于血糖偏高人群膳食营养补充的复合多维固体饮料配方及其制备工艺，由下列成分重量占比组成：大豆分离蛋白粉35％、浓缩乳清蛋白粉36％、菊粉10％、红枣粉14％、燕麦β-葡聚糖2％、柠檬酸钙1％、磷酸氢钙1.266398％、氧化镁0.22％、葡萄糖酸亚铁0.08％、葡萄糖酸锌0.05％、富硒麦芽粉0.0025％、醋酸维生素A0.001％、维生素B10.001％、维生素B20.001％、维生素B60.001％、维生素B120.000001％、维生素C0.1％、维生素D30.000001％、维生素E0.008％、烟酸0.011％、叶酸0.0001％、D-泛酸钙0.003％、葡萄籽提取物0.1％、叶黄素酯微囊粉0.005％、肉桂提取物0.15％。
优选的，一种适用于血糖偏高人群膳食营养补充的复合多维固体饮料配方及其制备工艺，由下列成分重量占比组成：大豆分离蛋白粉36％、浓缩乳清蛋白粉32.5％、菊粉12％、红枣粉14％、燕麦β-葡聚糖2％、柠檬酸钙1％、磷酸氢钙1.266398％、氧化镁0.22％、葡萄糖酸亚铁0.08％、葡萄糖酸锌0.05％、富硒麦芽粉0.0025％、醋酸维生素A0.001％、维生素B10.001％、维生素B20.001％、维生素B60.001％、维生素B120.000001％、维生素C0.1％、维生素D30.000001％、维生素E0.008％、烟酸0.011％、叶酸0.0001％、D-泛酸钙0.003％、葡萄籽提取物0.1％、叶黄素酯微囊粉0.005％、肉桂提取物0.65％。
一种适用于血糖偏高人群膳食营养补充的复合多维固体饮料配方及其制备工艺，包括如下制备方法：
步骤一，将大豆分离蛋白粉、浓缩乳清蛋白粉、菊粉、红枣粉、燕麦β-葡聚糖、柠檬酸钙、磷酸氢钙、氧化镁、葡萄糖酸亚铁、葡萄糖酸锌、富硒麦芽粉、醋酸维生素A、维生素B1、维生素B2、维生素B6、维生素B12、维生素C、维生素D3、维生素E、烟酸、叶酸、D-泛酸钙、葡萄籽提取物、叶黄素酯微囊粉与肉桂提取物按照相应质量占比进行称重，进而进行过筛处理。
步骤二，对大豆分离蛋白粉、浓缩乳清蛋白粉、菊粉、红枣粉进行预混处理；
步骤三，加入燕麦β-葡聚糖、柠檬酸钙、磷酸氢钙、氧化镁、葡萄糖酸亚铁、葡萄糖酸锌、富硒麦芽粉、醋酸维生素A、维生素B1、维生素B2、维生素B6、维生素B12、维生素C、维生素D3、维生素E、烟酸、叶酸、D-泛酸钙、葡萄籽提取物、叶黄素酯微囊粉与肉桂提取物进行总混处理；
步骤四，对混合后的原料进行采用内包装设备进行内包装处理；
步骤五，对内包装完成的半成品通过外包装设备进行外包装处理；
步骤六，对包装完成后的产品进行检验，检验合格后，进行入库，这样就完成了该产品的制备工艺。
燕麦β-葡聚糖：在降低血糖方面具有显著的作用。具体来说，这种成分能够增强胰岛素的敏感性，吸水后具有较高的黏度，在胃中能够延缓食物排空的速度，减少消化酶对碳水化合物的水解，并且抑制葡萄糖在小肠内的扩散和吸收，进而减缓葡萄糖吸收入血，减缓餐后血糖的上升速度，有助于维持血糖平稳；另外，燕麦β-葡聚糖还能够降低血液中的胆固醇水平，从而降低心血管疾病的风险。同时，它还可以促进肠道健康，增加粪便体积并加快肠道蠕动。
肉桂提取物：肉桂提取物中的活性成分如肉桂醇和肉桂醛等，具有增加胰岛素敏感性、降低血糖的作用。它能够刺激胰岛素的分泌，提高细胞对胰岛素的敏感性，进而促进血糖的代谢；肉桂提取物主要通过改善葡萄糖代谢、增加胰岛素敏感性、抑制糖异生和减少肠道对糖的吸收等途径来降低血糖。在临床研究中，肉桂提取物已被证明可以降低糖尿病患者的血糖水平，并且与胰岛素等药物合用时，能够增强降糖效果，减少药物剂量和副作用；此外，肉桂提取物还具有抗炎、抗氧化和抗肿瘤等作用，对心血管健康也有益处。它还能够改善血脂代谢，降低血脂水平，进一步预防心血管疾病的发生。
本发明的有益效果为：
本发明产品配方包含动物蛋白、植物蛋白、膳食纤维、维生素、矿物质及植物提取物等营养素，辅助人体肝脏血糖代谢，作为高血糖人群日常膳食营养补充，且该产品配比科学合理，无毒副作用，制备工艺简单成熟，针对血糖偏高者人群长期服用，具有显著效果，同时为人体提供各种必需营养物质，帮助人体维持正常的生理功能和代谢过程，从而保持健康，一方面进行营养补充：该产品富含多种维生素和矿物质，可以满足人体日常所需营养，特别是对于营养吸收不足的人群如老年人和慢病患者有很大的帮助；另一方面，增添的燕麦β-葡聚糖，有效增强胰岛素的敏感性，有助于维持血糖平稳，肉桂提取物中的活性成分如肉桂醇和肉桂醛等，具有增加胰岛素敏感性、降低血糖的作用。
具体实施方式
实施例一：一种适用于血糖偏高人群膳食营养补充的复合多维固体饮料配方及其制备工艺，由下列成分重量占比组成：大豆分离蛋白粉35kg、浓缩乳清蛋白粉36kg、菊粉10kg、红枣粉14kg、燕麦β-葡聚糖2kg、柠檬酸钙1kg、磷酸氢钙1.266398kg、氧化镁0.22kg、葡萄糖酸亚铁0.08kg、葡萄糖酸锌0.05kg、富硒麦芽粉0.0025kg、醋酸维生素A0.001kg、维生素B10.001kg、维生素B20.001kg、维生素B60.001kg、维生素B120.000001kg、维生素C0.1kg、维生素D30.000001kg、维生素E0.008kg、烟酸0.011kg、叶酸0.0001kg、D-泛酸钙0.003kg、葡萄籽提取物0.1kg、叶黄素酯微囊粉0.005kg、肉桂提取物0.15kg。
一种适用于血糖偏高人群膳食营养补充的复合多维固体饮料配方及其制备工艺，包括如下制备方法：
步骤一，将大豆分离蛋白粉35kg、浓缩乳清蛋白粉36kg、菊粉10kg、红枣粉14kg、燕麦β-葡聚糖2kg、柠檬酸钙1kg、磷酸氢钙1.266398kg、氧化镁0.22kg、葡萄糖酸亚铁0.08kg、葡萄糖酸锌0.05kg、富硒麦芽粉0.0025kg、醋酸维生素A0.001kg、维生素B10.001kg、维生素B20.001kg、维生素B60.001kg、维生素B120.000001kg、维生素C0.1kg、维生素D30.000001kg、维生素E0.008kg、烟酸0.011kg、叶酸0.0001kg、D-泛酸钙0.003kg、葡萄籽提取物0.1kg、叶黄素酯微囊粉0.005kg与肉桂提取物0.15kg按照相应质量占比进行称重，进而进行过筛处理。
步骤二，对大豆分离蛋白粉35kg、浓缩乳清蛋白粉36kg、菊粉10kg、红枣粉14kg进行预混处理；
步骤三，加入燕麦β-葡聚糖2kg、柠檬酸钙1kg、磷酸氢钙1.266398kg、氧化镁0.22kg、葡萄糖酸亚铁0.08kg、葡萄糖酸锌0.05kg、富硒麦芽粉0.0025kg、醋酸维生素A0.001kg、维生素B10.001kg、维生素B20.001kg、维生素B60.001kg、维生素B120.000001kg、维生素C0.1kg、维生素D30.000001kg、维生素E0.008kg、烟酸0.011kg、叶酸0.0001kg、D-泛酸钙0.003kg、葡萄籽提取物0.1kg、叶黄素酯微囊粉0.005kg与肉桂提取物0.15kg进行总混处理；
步骤四，对混合后的原料进行采用内包装设备进行内包装处理；
步骤五，对内包装完成的半成品通过外包装设备进行外包装处理；
步骤六，对包装完成后的产品进行检验，检验合格后，进行入库，这样就完成了该产品的制备工艺。
本发明产品配方包含动物蛋白、植物蛋白、膳食纤维、维生素、矿物质及植物提取物等营养素，辅助人体肝脏血糖代谢，作为高血糖人群日常膳食营养补充，服用方法为每日3次，每次1袋。包装规格：25g/袋*21袋/盒。
实施例二：一种适用于血糖偏高人群膳食营养补充的复合多维固体饮料配方及其制备工艺，由下列成分重量占比组成：大豆分离蛋白粉36kg、浓缩乳清蛋白粉32.5kg、菊粉12kg、红枣粉14kg、燕麦β-葡聚糖2kg、柠檬酸钙1kg、磷酸氢钙1.266398kg、氧化镁0.22kg、葡萄糖酸亚铁0.08kg、葡萄糖酸锌0.05kg、富硒麦芽粉0.0025kg、醋酸维生素A0.001kg、维生素B10.001kg、维生素B20.001kg、维生素B60.001kg、维生素B120.000001kg、维生素C0.1kg、维生素D30.000001kg、维生素E0.008kg、烟酸0.011kg、叶酸0.0001kg、D-泛酸钙0.003kg、葡萄籽提取物0.1kg、叶黄素酯微囊粉0.005kg、肉桂提取物0.65kg。
一种适用于血糖偏高人群膳食营养补充的复合多维固体饮料配方及其制备工艺，包括如下制备方法：
步骤一，将大豆分离蛋白粉36kg、浓缩乳清蛋白粉32.5kg、菊粉12kg、红枣粉14kg、燕麦β-葡聚糖2kg、柠檬酸钙1kg、磷酸氢钙1.266398kg、氧化镁0.22kg、葡萄糖酸亚铁0.08kg、葡萄糖酸锌0.05kg、富硒麦芽粉0.0025kg、醋酸维生素A0.001kg、维生素B10.001kg、维生素B20.001kg、维生素B60.001kg、维生素B120.000001kg、维生素C0.1kg、维生素D30.000001kg、维生素E0.008kg、烟酸0.011kg、叶酸0.0001kg、D-泛酸钙0.003kg、葡萄籽提取物0.1kg、叶黄素酯微囊粉0.005kg与肉桂提取物0.65kg按照相应质量占比进行称重，进而进行过筛处理。
步骤二，对大豆分离蛋白粉36kg、浓缩乳清蛋白粉32.5kg、菊粉12kg、红枣粉14kg进行预混处理；
步骤三，加入燕麦β-葡聚糖2kg、柠檬酸钙1kg、磷酸氢钙1.266398kg、氧化镁0.22kg、葡萄糖酸亚铁0.08kg、葡萄糖酸锌0.05kg、富硒麦芽粉0.0025kg、醋酸维生素A0.001kg、维生素B10.001kg、维生素B20.001kg、维生素B60.001kg、维生素B120.000001kg、维生素C0.1kg、维生素D30.000001kg、维生素E0.008kg、烟酸0.011kg、叶酸0.0001kg、D-泛酸钙0.003kg、葡萄籽提取物0.1kg、叶黄素酯微囊粉0.005kg与肉桂提取物0.65kg进行总混处理；
步骤四，对混合后的原料进行采用内包装设备进行内包装处理；
步骤五，对内包装完成的半成品通过外包装设备进行外包装处理；
步骤六，对包装完成后的产品进行检验，检验合格后，进行入库，这样就完成了该产品的制备工艺。
本发明产品配方包含动物蛋白、植物蛋白、膳食纤维、维生素、矿物质及植物提取物等营养素，辅助人体肝脏血糖代谢，作为高血糖人群日常膳食营养补充，服用方法为每日3次，每次1袋。包装规格：25g/袋*21袋/盒。
Claims (4)
1.一种适用于血糖偏高人群膳食营养补充的复合多维固体饮料配方及其制备工艺，其特征在于，由下列成分重量占比组成：大豆分离蛋白粉10％-38％、浓缩乳清蛋白粉10％-38％、菊粉10％-21％、红枣粉14％-16％、燕麦β-葡聚糖2％-4.5％、柠檬酸钙1％-4.15％、磷酸氢钙1％-3.1％、氧化镁0.22％-0.34％、葡萄糖酸亚铁0.08％-0.17％、葡萄糖酸锌0.05％-0.12％、富硒麦芽粉0.0025％-0.01％、醋酸维生素A0.001％-0.0017％、维生素B10.001％-0.002％、维生素B20.001％-0.002％、维生素B60.001％-0.002％、维生素B120.000001％-0.000006％、维生素C0.1％-0.2％、维生素D30.000001％-0.000002％、维生素E0.008％-0.018％、烟酸0.011％-0.03％、叶酸0.0001％-0.0006％、D-泛酸钙0.003％-0.008％、葡萄籽提取物0.1％-0.5％、叶黄素酯微囊粉0.005％-0.15％、肉桂提取物0.15％-0.75％。
2.根据权利要求1所述的一种适用于血糖偏高人群膳食营养补充的复合多维固体饮料配方及其制备工艺，其特征在于：由下列成分重量占比组成：大豆分离蛋白粉35％、浓缩乳清蛋白粉36％、菊粉10％、红枣粉14％、燕麦β-葡聚糖2％、柠檬酸钙1％、磷酸氢钙1.266398％、氧化镁0.22％、葡萄糖酸亚铁0.08％、葡萄糖酸锌0.05％、富硒麦芽粉0.0025％、醋酸维生素A0.001％、维生素B10.001％、维生素B20.001％、维生素B60.001％、维生素B120.000001％、维生素C0.1％、维生素D30.000001％、维生素E0.008％、烟酸0.011％、叶酸0.0001％、D-泛酸钙0.003％、葡萄籽提取物0.1％、叶黄素酯微囊粉0.005％、肉桂提取物0.15％。
3.根据权利要求1所述的一种适用于血糖偏高人群膳食营养补充的复合多维固体饮料配方及其制备工艺，其特征在于：由下列成分重量占比组成：大豆分离蛋白粉36％、浓缩乳清蛋白粉32.5％、菊粉12％、红枣粉14％、燕麦β-葡聚糖2％、柠檬酸钙1％、磷酸氢钙1.266398％、氧化镁0.22％、葡萄糖酸亚铁0.08％、葡萄糖酸锌0.05％、富硒麦芽粉0.0025％、醋酸维生素A0.001％、维生素B10.001％、维生素B20.001％、维生素B60.001％、维生素B120.000001％、维生素C0.1％、维生素D30.000001％、维生素E0.008％、烟酸0.011％、叶酸0.0001％、D-泛酸钙0.003％、葡萄籽提取物0.1％、叶黄素酯微囊粉0.005％、肉桂提取物0.65％。
4.根据权利要求1-3任意一项所述的一种适用于血糖偏高人群膳食营养补充的复合多维固体饮料配方及其制备工艺，包括如下制备方法：
步骤一，将大豆分离蛋白粉、浓缩乳清蛋白粉、菊粉、红枣粉、燕麦β-葡聚糖、柠檬酸钙、磷酸氢钙、氧化镁、葡萄糖酸亚铁、葡萄糖酸锌、富硒麦芽粉、醋酸维生素A、维生素B1、维生素B2、维生素B6、维生素B12、维生素C、维生素D3、维生素E、烟酸、叶酸、D-泛酸钙、葡萄籽提取物、叶黄素酯微囊粉与肉桂提取物按照相应质量占比进行称重，进而进行过筛处理。
步骤二，对大豆分离蛋白粉、浓缩乳清蛋白粉、菊粉、红枣粉进行预混处理；
步骤三，加入燕麦β-葡聚糖、柠檬酸钙、磷酸氢钙、氧化镁、葡萄糖酸亚铁、葡萄糖酸锌、富硒麦芽粉、醋酸维生素A、维生素B1、维生素B2、维生素B6、维生素B12、维生素C、维生素D3、维生素E、烟酸、叶酸、D-泛酸钙、葡萄籽提取物、叶黄素酯微囊粉与肉桂提取物进行总混处理；
步骤四，对混合后的原料进行采用内包装设备进行内包装处理；
步骤五，对内包装完成的半成品通过外包装设备进行外包装处理；
步骤六，对包装完成后的产品进行检验，检验合格后，进行入库，这样就完成了该产品的制备工艺。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202410127411.0A CN117694480A (zh) | 2024-01-30 | 2024-01-30 | 一种适用于血糖偏高人群膳食营养补充的复合多维固体饮料配方及其制备工艺 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202410127411.0A CN117694480A (zh) | 2024-01-30 | 2024-01-30 | 一种适用于血糖偏高人群膳食营养补充的复合多维固体饮料配方及其制备工艺 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN117694480A true CN117694480A (zh) | 2024-03-15 |
Family
ID=90157371
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202410127411.0A Pending CN117694480A (zh) | 2024-01-30 | 2024-01-30 | 一种适用于血糖偏高人群膳食营养补充的复合多维固体饮料配方及其制备工艺 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN117694480A (zh) |
-
2024
- 2024-01-30 CN CN202410127411.0A patent/CN117694480A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101143010B (zh) | 糖尿病患者专用营养食品制备方法 | |
| CN101878790B (zh) | 一种糖尿病专用强化营养面粉及其制备方法 | |
| CN103725469B (zh) | 一种养生干红葡萄酒 | |
| CN103238897A (zh) | 一种适用于糖尿病人的复合植物固体饮料 | |
| CN103168812A (zh) | 一种无蔗糖苦荞饼干及其制作方法 | |
| KR102396152B1 (ko) | 간편식 영양균형 건강식품 | |
| CN105876585A (zh) | 蛋白质固体饮料、其制备方法及其应用 | |
| CN103141741A (zh) | 一种含有丰富膳食纤维的食品添加原料及其应用 | |
| CN111728202A (zh) | 一种适用于糖尿病患者的食品组合物及制备方法 | |
| CN110101088A (zh) | 用于妊娠糖尿病防治的精准营养代餐组合物及其使用方法 | |
| CN108782874A (zh) | 一种富硒红茶饮料 | |
| CN110623270A (zh) | 一种活力餐及其制备方法 | |
| CN107223981B (zh) | 含大豆多肽阿格拉欣的组合物及其制备方法 | |
| CN105410930A (zh) | 一种具有减肥瘦身、均衡营养功能的保健品及其制备方法 | |
| CN1082838A (zh) | 糖尿病药食两用系列 | |
| CN101253984A (zh) | 蜂王浆银杏叶营养保健品及其制备方法 | |
| KR20040024774A (ko) | 혈액형별 체질에 적합하도록 제조한 생약 조성물 | |
| CN106360742A (zh) | 一种用于肥胖或减脂手术患者的营养食品组合物 | |
| CN117694480A (zh) | 一种适用于血糖偏高人群膳食营养补充的复合多维固体饮料配方及其制备工艺 | |
| US7416750B1 (en) | Composition to provide maintenance and nutritional support in glycemic control deficits | |
| CN107136490A (zh) | 一种肽虫草保健品 | |
| CN100420457C (zh) | 苦荞螺旋藻片剂及其制备方法 | |
| CN107173654A (zh) | 一种保健饮料及其制备方法 | |
| RU2358562C1 (ru) | Концентрат растительный для функционального напитка "казан-бионан-3" | |
| CN100404069C (zh) | 火麻仁球蛋白在制备抗缺氧功能食品中的应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |